Anti-MTA1 antibody
4
(10 Reviews)
|
(43 Publications)
Rabbit Polyclonal MTA1 antibody. Suitable for IHC-P, IP, WB and reacts with Human, Mouse samples. Cited in 43 publications. Immunogen corresponding to Synthetic Peptide within Human MTA1.
View Alternative Names
Metastasis-associated protein MTA1, MTA1
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MTA1 antibody (AB71153)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human non-small cell lung cancer tissue labelling MTA1 with ab71153 at 1/1000 (0.2 µg/ml). Detection : DAB.
- IP
Unknown
Immunoprecipitation - Anti-MTA1 antibody (AB71153)
Immunoprecipitation/ Western Blot of MTA1
Lane 1 : ab71153 at 3μg/mg whole cell lysate.
Lane 2 : Control IgG.
Whole cell lysate from Hela cells at 1mg for IP, 20% of IP loaded.
Subsequent WB detection was performed using 1 μg/ml ab71153.
Chemiluminescence with an exposure time of 1 second.
All lanes:
Immunoprecipitation - Anti-MTA1 antibody (ab71153)
Predicted band size: 81 kDa
false
- WB
Lab
Western blot - Anti-MTA1 antibody (AB71153)
False colour image of Western blot : Anti-MTA1 antibody staining at 1/2000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab71153 was shown to bind specifically to MTA1. A band was observed at 80/85 kDa in wild-type HEK-293 cell lysates with no signal observed at this size in Mta1 CRISPR-Cas9 edited cell line ab277164 (CRISPR-Cas9 edited cell lysate ab277206). The band observed in the CRISPR-Cas9 edited lysate lane below 80/85 kDa is likely to represent a truncated form of MTA1. This has not been investigated further and the functional properties of the gene product have not been determined. To generate this image, wild-type and Mta1 CRISPR-Cas9 edited HEK-293 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3% milk in TBS-0.1% Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-MTA1 antibody (ab71153) at 1/2000 dilution
Lane 1:
Wild-type HEK-293 cell lysate at 20 µg
Lane 2:
Mta1 CRISPR-Cas9 edited HEK-293 cell lysate at 20 µg
Lane 3:
Jurkat cell lysate at 20 µg
Lane 4:
MCF7 cell lysate at 20 µg
false
- WB
Unknown
Western blot - Anti-MTA1 antibody (AB71153)
All lanes:
Western blot - Anti-MTA1 antibody (ab71153) at 0.1 µg/mL
Lane 1:
HeLa whole cell lysate at 50 µg
Lane 2:
HEK293T whole cell lysate at 50 µg
Lane 3:
Jurkat whole cell lysate at 50 µg
Lane 4:
TCMK whole cell lysate at 50 µg
Predicted band size: 81 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
MTA1 contributes to regulating diverse cellular processes. It forms part of the NuRD complex which plays a critical role in mediating chromatin remodeling and histone deacetylation. This association enables MTA1 to influence key aspects of cellular behavior including cell proliferation differentiation and response to stress. The protein's involvement extends to modulating transcription factors and interacting with several other proteins impacting cellular growth and metastasis.
Pathways
MTA1 participates actively in the regulation of several key signaling networks. One significant pathway is the Wnt/β-catenin signaling pathway where MTA1 modulates gene expression by interacting with β-catenin. In another pathway it affects the estrogen receptor signaling pathway impacting gene transcription in hormone-dependent cancers. MTA1’s interaction with HDAC (Histone deacetylase) proteins emphasizes its role in epigenetic regulation across different biological pathways.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (43)
Recent publications for all applications. Explore the full list and refine your search
American journal of cancer research 12:5646-5656 PubMed36628289
2022
Applications
Unspecified application
Species
Unspecified reactive species
Neoplasma 69:1092-1100 PubMed35951452
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 38:110534 PubMed35320709
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 12:825783 PubMed35350571
2022
Applications
Unspecified application
Species
Unspecified reactive species
Mediators of inflammation 2021:6359652 PubMed34924813
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 25: PubMed34779499
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cancer management and research 13:7087-7099 PubMed34531686
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cell death and differentiation 28:2818-2836 PubMed33953349
2021
Applications
Unspecified application
Species
Unspecified reactive species
Oncology reports 45: PubMed33786627
2021
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 20:172 PubMed32934739
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com